Semaglutide versus tirzepatide is the most common comparison, but newer compounds like retatrutide are also entering the picture
Note: Patients with heart failure or kidney disease should follow their provider's fluid intake recommendations
Blanket recommendations miss the mark
reports consultancy (contracted via the University of Liverpool) from Astellas, AstraZeneca, Boehringer Ingelheim, Janssen Pharmaceuticals, Lilly, Mundipharma, Napp, Novo Nordisk, Rhythm Pharmaceuticals, Sanofi, and Wilmington Healthcare, honoraria/lecture fees from AstraZeneca, Boehringer Ingelheim, Lilly, Mundipharma, Napp, Sanofi, and Takeda, and has received support to attend conferences from AstraZeneca, Napp, and Novo Nordisk
Some users may find Mounjaro to be a more suitable option based on their tolerance and the severity of side effects